TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy

Abstract Background Genetic variants of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) confer increased risk of developing late-onset Alzheimer’s Disease (LOAD) and other neurodegenerative disorders. Recent studies provided insight into the multifaceted roles of TREM2 in regulating ext...

Full description

Bibliographic Details
Main Authors: Shane M. Bemiller, Tyler J. McCray, Kevin Allan, Shane V. Formica, Guixiang Xu, Gina Wilson, Olga N. Kokiko-Cochran, Samuel D. Crish, Cristian A. Lasagna-Reeves, Richard M. Ransohoff, Gary E. Landreth, Bruce T. Lamb
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Molecular Neurodegeneration
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13024-017-0216-6
_version_ 1818300539570487296
author Shane M. Bemiller
Tyler J. McCray
Kevin Allan
Shane V. Formica
Guixiang Xu
Gina Wilson
Olga N. Kokiko-Cochran
Samuel D. Crish
Cristian A. Lasagna-Reeves
Richard M. Ransohoff
Gary E. Landreth
Bruce T. Lamb
author_facet Shane M. Bemiller
Tyler J. McCray
Kevin Allan
Shane V. Formica
Guixiang Xu
Gina Wilson
Olga N. Kokiko-Cochran
Samuel D. Crish
Cristian A. Lasagna-Reeves
Richard M. Ransohoff
Gary E. Landreth
Bruce T. Lamb
author_sort Shane M. Bemiller
collection DOAJ
description Abstract Background Genetic variants of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) confer increased risk of developing late-onset Alzheimer’s Disease (LOAD) and other neurodegenerative disorders. Recent studies provided insight into the multifaceted roles of TREM2 in regulating extracellular β-amyloid (Aβ) pathology, myeloid cell accumulation, and inflammation observed in AD, yet little is known regarding the role of TREM2 in regulating intracellular microtubule associated protein tau (MAPT; tau) pathology in neurodegenerative diseases and in AD, in particular. Results Here we report that TREM2 deficiency leads to accelerated and exacerbated hyperphosphorylation and aggregation of tau in a humanized mouse model of tauopathy. TREM2 deficiency also results, indirectly, in dramatic widespread dysregulation of neuronal stress kinase pathways. Conclusions Our results suggest that deficiency of microglial TREM2 leads to heightened tau pathology coupled with widespread increases in activated neuronal stress kinases. These findings offer new insight into the complex, multiple roles of TREM2 in regulating Aβ and tau pathologies.
first_indexed 2024-12-13T05:08:44Z
format Article
id doaj.art-d537fc31545b4db78783ea737d60c189
institution Directory Open Access Journal
issn 1750-1326
language English
last_indexed 2024-12-13T05:08:44Z
publishDate 2017-10-01
publisher BMC
record_format Article
series Molecular Neurodegeneration
spelling doaj.art-d537fc31545b4db78783ea737d60c1892022-12-21T23:58:35ZengBMCMolecular Neurodegeneration1750-13262017-10-0112111210.1186/s13024-017-0216-6TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathyShane M. Bemiller0Tyler J. McCray1Kevin Allan2Shane V. Formica3Guixiang Xu4Gina Wilson5Olga N. Kokiko-Cochran6Samuel D. Crish7Cristian A. Lasagna-Reeves8Richard M. Ransohoff9Gary E. Landreth10Bruce T. Lamb11Department of Neurosciences, The Cleveland Clinic Lerner Research InstituteIndiana University School of Medicine Stark Neuroscience Research InstituteDepartment of Neurosciences, Case Western Reserve UniversityDepartment of Neurosciences, The Cleveland Clinic Lerner Research InstituteDepartment of Neurosciences, The Cleveland Clinic Lerner Research InstituteDepartment of Neurosciences, Northeastern Ohio Medical UniversityDepartment of Neurosciences, The Cleveland Clinic Lerner Research InstituteDepartment of Neurosciences, Northeastern Ohio Medical UniversityIndiana University School of Medicine Stark Neuroscience Research InstituteBiogen IDECIndiana University School of Medicine Stark Neuroscience Research InstituteDepartment of Neurosciences, The Cleveland Clinic Lerner Research InstituteAbstract Background Genetic variants of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) confer increased risk of developing late-onset Alzheimer’s Disease (LOAD) and other neurodegenerative disorders. Recent studies provided insight into the multifaceted roles of TREM2 in regulating extracellular β-amyloid (Aβ) pathology, myeloid cell accumulation, and inflammation observed in AD, yet little is known regarding the role of TREM2 in regulating intracellular microtubule associated protein tau (MAPT; tau) pathology in neurodegenerative diseases and in AD, in particular. Results Here we report that TREM2 deficiency leads to accelerated and exacerbated hyperphosphorylation and aggregation of tau in a humanized mouse model of tauopathy. TREM2 deficiency also results, indirectly, in dramatic widespread dysregulation of neuronal stress kinase pathways. Conclusions Our results suggest that deficiency of microglial TREM2 leads to heightened tau pathology coupled with widespread increases in activated neuronal stress kinases. These findings offer new insight into the complex, multiple roles of TREM2 in regulating Aβ and tau pathologies.http://link.springer.com/article/10.1186/s13024-017-0216-6TREM2TauopathyAlzheimers diseaseInflammationImmunity
spellingShingle Shane M. Bemiller
Tyler J. McCray
Kevin Allan
Shane V. Formica
Guixiang Xu
Gina Wilson
Olga N. Kokiko-Cochran
Samuel D. Crish
Cristian A. Lasagna-Reeves
Richard M. Ransohoff
Gary E. Landreth
Bruce T. Lamb
TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
Molecular Neurodegeneration
TREM2
Tauopathy
Alzheimers disease
Inflammation
Immunity
title TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
title_full TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
title_fullStr TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
title_full_unstemmed TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
title_short TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
title_sort trem2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
topic TREM2
Tauopathy
Alzheimers disease
Inflammation
Immunity
url http://link.springer.com/article/10.1186/s13024-017-0216-6
work_keys_str_mv AT shanembemiller trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT tylerjmccray trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT kevinallan trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT shanevformica trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT guixiangxu trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT ginawilson trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT olgankokikocochran trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT samueldcrish trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT cristianalasagnareeves trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT richardmransohoff trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT garyelandreth trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy
AT brucetlamb trem2deficiencyexacerbatestaupathologythroughdysregulatedkinasesignalinginamousemodeloftauopathy